Strategies for particle design using supercritical fluid technologies

Pharmaceutical Science and Technology Today

Volumn 2, Issue 11, 1999, Pages 430-440

  York, Peter ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC ACID; PARACETAMOL;

DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SOLUBILITY; PARTICLE SIZE; PRECIPITATION; REVIEW; SUPERCRITICAL FLUID EXTRACTION;

EID: 0033230727     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(99)00209-6     Document Type: Review

References (66)

1. Brennecke, J.F. and Eckert, C.A. (1989) Am. Inst. Chem. Eng. J. 35, 1409-1427
2. Tom, J.W. and Debenedetti, P.G. (1991) J. Aerosol Sci. 22, 555-584
3. Hanny, J.B. and Hogarth, J. (1879) Proc. R. Soc. London 29, 324-326
4. Andrews, T. (1875) Proc. R. Soc. London 24, 455-463
5. McHugh, M. and Krukonis, V. (1994) Supercritical Fluid Extraction Principles and Practice, (2nd Edn), Butterworth-Heinemann
6. Clifford, A.A. and Bartle, K.D. (1996) Chem. Ind. 12, 449-452
7. Larson, K.A. and King, M.L. (1986) Biotechnol. Prog. 2, 73-82
8. Schmitt, W.J. and Reid, R.C. (1986) Fluid Phase Equilibria 32, 77-99
9. Brunner, E.J. (1985) Chem. Thermochim. 17, 672-679
10. Gurdial, G.S. et al. (1993) Ind. Eng. Chem. Res. 32, 1488-1497
11. Palakodaty, S. et al. (1997) Proc. 16th Pharm. Tech. Conf., Athens, Greece, pp. 22-28
12. Bristow, S.C. et al. (1998) J. Pharm. Pharmacol. 50, 535
13. Debendetti, P.G. (1994) in Supercritical Fluids: Fundamentals for Application, (Vol. 273), NATO ASI Series E
14. Phillips, E.M. and Stella, V.J. (1993) Int. J. Pharm. 94, 1-10
15. Subramaniam, B. et al. (1997) J. Pharm. Sci. 86, 885-890
16. Weidner, E. et al. (1996) in High Pressure Chemical Engineering, Process Technol. Proceedings, 12, Elsevier
17. Palakodaty, S. and York, P. (1999) Pharm. Res. 16, 976-985
18. Matson, D.W. et al. (1987) Ind. Eng. Chem. Res. 26, 2298-2306
19. Kuwauk, X. and Debenedetti, P.G. (1993) J. Aerosol. Sci. 24, 445-447
20. Borends, E.M. et al. (1994) in Proc. 3rd Int. Symp. Supercrit. Fluids, Soc. Adv. Sup. Fluids, Vandoeuvre-les-Nancy, France
21. Shaube, G.R. (1995) J. Supercrit. Fluids 8, 318-328
22. Reverchon, E. and Pallado, P. (1996) J. Supercrit. Fluids 9, 216-221
23. Reverchon, E. (1999) J. Supercrit. Fluids 15, 1-21
24. Tom, J.W. and Debenedetti, P.G. (1991) Biotechnol. Prog. 7, 403-411
25. Lele, A.K. and Shine, A.D. (1992) AIChE J. 38, 742-752
26. Ohgaki, K. et al. (1990) J. Supercrit. Fluids, 3, 103-107
27. Subra, P. and Debenedetti, P. (1996) in High pressure chemical engineering, Process Technol. Proceedings, 12, Elsevier
28. Tom, J.W. et al. (1993) ACS Symp. Series 514, 238-257
29. Tom, T.W. and Debenedetti, P. (1994) J. Supercrit. Fluids 7, 9-29
30. Kim, J.H. et al. (1996) Biotechnol. Prog. 12, 650-661
31. Kiran, E. and Zhuang, W. (1997) ACS Symp. Ser. 670, 2-36
32. Wubbolts, F.E. et al. (1998) in Proc. 5th Int. Symp. Supercrit. Fluids, Soc. Adv. Sup. Fluids, Nice, France
33. Tom, J.E. et al. (1993) ACS Symp. Series 514, 238-257
34. Yeo, S.D. et al. (1993) Biotechnol. Bioeng. 41, 341-346
35. Bleich, J. et al. (1993) Int. J. Pharm. 97, 111-117
36. Dixon, D.J. et al. (1993) AIChE J. 39, 127-139
37. York, P. and Hanna, M.H. (1996) Proc. Resp. Drug Delivery V, Phoenix, AZ, USA, pp. 231-239
38. York, P. et al. (1998) Proc. Resp. Drug Delivery VI, Hilton Head, USA pp. 169-175
39. Sloan, R. et al. (1998) in Proc. 5th Int. Symp. Supercrit. Fluids, Soc. Adv. Sup. Fluids, Nice, France, pp. 301-306
40. Shekunov, B. Yu. et al. (1999) J. Cryst Growth 198/199, 1345-1351
41. Shekunov, B. Yu et al. (1998) Pharm. Res. 15, S162
42. Ruchatz, F. et al. (1997) J. Pharm. Sci. 86, 101-105
43. Phillips, E.M. and Stella, V.J. (1993) Int. J. Pharm. 94, 1-10
44. Ward, G.H. and Shultz, R. (1995) Pharm. Res. 12, 773-779
45. Yeo, S.D. et al. (1993) Biotech. Bioeng. 41, 341-346
46. Yeo, S.D. et al. (1994) J. Pharm. Sci. 83, 1651-1656
47. Winters, M.A. et al. (1996) J. Pharm. Sci. 85, 586-594
48. Schmitt, W.J. (1995) AIChE J. 41, 2476-2486
49. Bisrat, M. and Mushashahee, S. (1998) PCT Patent Application WO 98/52544
50. Feeley, J. et al. (1998) Drug Delivery to the Lungs IX, The Aerosol Society, London, UK, pp. 196-199
51. Beach, S. et al. Organic Proc. Res. Dev. (in press)
52. Cooper, S.M. (1998) PCT Patent Application WO 98/17676
53. Jaarmo, S. et al. (1997) in Proc. 4th Int. Symp. Supercrit. Fluids (K. Arai, ed.) 11-14 May, pp. 263-267
54. York, P. and Hanna, M. (1998) Drug Delivery to the Lungs IX Conference, The Aerosol Society, London, UK, pp. 200-204
55. Alsoy, S. and Duda, J.L. (1998) AIChE J. 44, 582-590
56. Hanna, M.H. et al. Pharm. Res. (in press)
57. Lucien, F.P. and Foster, N.R. (1998) J. Chem. Eng. Data 43, 726-731
58. Kordikowski, A. et al. J. Pharm. Sci. (in press)
59. Bunyan, J.M.E. et al. (1991) AIChE Symp. Ser. 87, 44-50
60. Forbes, R.T. et al. (1998) Proc. IChE World Congress on Particle Technology 3, Brighton, UK, pp. 180-184
61. Sloan, R. et al. (1999) Proc. 6th Meeting Supercrit. Fluids, Nottingham, UK, pp. 169-174
62. Subramaniam, B. et al. (1997) J. Pharm. Sci. 86, 885-890
63. Bleich, J. and Muller, B.W. (1996) J. Microencap. 13, 131-139
64. Wilkins, S. et al. J. Pharm. Pharmacol. (in press)
65. Steckel, H. and Müller, B.W. (1998) Int. J. Pharm 173, 25-33
66. Thies, J. and Müller, B.W. (1998) Eur. J. Pharm. Biopharm. 45, 67-74